![Anthony Andrasfay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Andrasfay
No open positions remaining
Profile
Anthony Andrasfay is Vice President of Clinical Operations for Cardium Therapeutics, Inc., which he joined in November 2005.
He was an Associate Director of Clinical Research for Idun Pharmaceuticals, Clinical Research Manager of Collateral Therapeutics from 1999 to 2003, Project Manager of Clinical Development for Dura Pharmaceuticals, Inc. from 1996 to 1999 and Manager of Clinical Research for Gensia, Inc. from 1992 to 1996.
Mr. Andrasfay received a BS in Biological Sciences from the University of California, Irvine.
Former positions of Anthony Andrasfay
| Companies | Position | End |
|---|---|---|
Cardium Therapeutics, Inc. /Old/
 Cardium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops therapeutics and treatments for coronary artery disease and heart attacks | Chief Tech/Sci/R&D Officer | 2006-01-22 |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Corporate Officer/Principal | 2002-12-31 |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Corporate Officer/Principal | 1998-12-31 |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 1995-12-31 |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics and conducts medical research | Corporate Officer/Principal | - |
Training of Anthony Andrasfay
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Commercial Services |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics and conducts medical research | Health Technology |
Cardium Therapeutics, Inc. /Old/
Cardium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops therapeutics and treatments for coronary artery disease and heart attacks | Commercial Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- Anthony Andrasfay
